First findings of virtual reality exposure therapy for PTSD

April 22, 2014 by Robin Reese, Emory University
The virtual reality exposure therapy involved 30-45 minutes of exposure to virtual environments on a head mounted video display that attempt to match stimuli described by the veteran.

(Medical Xpress)—A randomized controlled clinical trial of Iraq and Afghanistan veterans with post-traumatic stress disorder (PTSD) found that shorter doses of virtual reality exposure therapy (VRE) reduces PTSD diagnoses and symptoms. The study was published in the April 18, 2014 online edition of the American Journal of Psychiatry.

Researchers at Emory University conducted the study with 156 veterans with combat-related PTSD. After an introductory session, each veteran was randomly assigned to receive d-cycloserine (DCS) (53 subjects), alprazolam (50 subjects), or a placebo (53 subjects) before each of five sessions of VRE.

The study found PTSD symptoms significantly improved from pre- to post-treatment with the VRE therapy and the DCS may enhance the VRE results for those veterans who demonstrated better emotional learning in sessions. In addition to self-reported symptoms, researchers used objective measures of cortisol, a stress hormone, and the startle response, and found reductions in reactivity after treatment. Alprazolam, known more commonly as Xanax, impaired recovery from symptoms.

"D-cycloserine, combined with only five sessions of the virtual reality exposure therapy, was associated with significant improvements in objective measures of startle and cortisol and overall PTSD symptoms for those who showed emotional learning in sessions," says lead researcher Barbara Rothbaum, PhD, professor of psychiatry and behavioral sciences at Emory University School of Medicine and director of the Trauma and Anxiety Recovery Program.

Exposure therapy is an evidence-based intervention that has been demonstrated as effective in the treatment of Posttraumatic Stress Disorder (PTSD). During each exposure therapy session, patients repeatedly retell their traumatic experience with the guidance of a trained clinician as well as immersion in a virtual reality simulation. D-Cycloserine, a cognitive enhancer, has been found by Emory researchers to facilitate the extinction of fear that occurs during exposure therapy. One of the pioneers in this type of therapy is Emory's Barbara Rothbaum, PhD, who in this video describes the symptoms of PTSD and the various treatments currently available.

The double-blind, placebo-controlled study consisted of an initial screening assessment, six treatment visits, and follow-up assessments at three, six and 12 months post-treatment. The virtual reality exposure therapy involved 30-45 minutes of exposure to virtual environments on a head mounted video display that attempt to match stimuli described by the veteran. Scenes depict a variety of Iraq and Afghanistan environments, including street scenes and neighborhoods, as well as from different points of view, i.e. as a driver, passenger, or walking on foot. Thirty minutes before each session, participants took a single pill.

"We were very excited to see the substantial gains in self-reported and objective indices of PTSD with only five sessions of the combined," says Rothbaum.

Explore further: Can virtual reality-based therapy help veterans overcome posttraumatic stress disorder?

Related Stories

Can virtual reality-based therapy help veterans overcome posttraumatic stress disorder?

March 25, 2014
Posttraumatic stress disorder (PTSD) is common among military veterans and together with the often-related anxiety, depression, and psychological and emotional impairment can dramatically affect quality of life. A type of ...

PTSD psychotherapy is enhanced with D-cycloserine

June 4, 2012
Posttraumatic stress disorder (PTSD) is among the most common, distressing, and disabling medical consequences of combat or other extremely stressful life events. The first-line treatment for PTSD is exposure therapy, a type ...

Treating PTSD and alcohol abuse together doesn't increase drinking, study finds

August 6, 2013
Contrary to past concerns, using prolonged exposure therapy to treat patients with post-traumatic stress disorder (PTSD) and comorbid alcohol dependence does not increase drinking or cravings, Penn Medicine psychiatrists ...

Prolonged exposure therapy found beneficial in treating adolescent girls with PTSD

December 24, 2013
Researchers at Penn Medicine report in the December 25 issue of JAMA that a modified form of prolonged exposure therapy – in which patients revisit and recount aloud their trauma-related thoughts, feelings and situations ...

Depression symptoms and emotional support impact PTSD treatment progress

January 23, 2014
Many individuals with posttraumatic stress disorder (PTSD) also experience depression. Researchers at Case Western Reserve University found that during PTSD treatments, rapid improvements in depression symptoms are associated ...

Recommended for you

People expect their memory to fade as early as their 50s

April 24, 2018
People across the UK expect their memory to worsen in their 50s, according to new research from Heriot-Watt University.

Imagining a positive outcome biases subsequent memories

April 24, 2018
Imagining that a future event will go well may lead you to remember it more positively after it's over, according to findings from research published in Psychological Science, a journal of the Association for Psychological ...

Depressed, inactive and out of work—study reveals lives of lonely young adults

April 24, 2018
New research from King's College London shows that lonely young adults are more likely to experience mental health problems and more likely to be out of work than their peers. The study, published today in Psychological Medicine, ...

Sense of control and meaning helps protect women from anxiety

April 24, 2018
People who feel in control of their lives and who find purpose and meaning in life are less likely to have anxiety disorders even when going through the toughest times, according to a study led by the University of Cambridge.

Researchers identify brain mechanism linking PTSD and opioid addiction

April 23, 2018
Researchers at Western University have shown that the recall of traumatic memories enhances the rewarding effects of morphine, shedding light on the neurobiological link between post-traumatic stress disorder (PTSD) and opioid ...

Scientific guidelines for using cannabis to treat stress, anxiety and depression

April 19, 2018
In a first-of-a-kind study, Washington State University scientists examined how peoples' self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.